GenoFocus Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Eui-Joong Kim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership9.3%
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

There's Reason For Concern Over GenoFocus, Inc.'s (KOSDAQ:187420) Massive 30% Price Jump

Oct 29
There's Reason For Concern Over GenoFocus, Inc.'s (KOSDAQ:187420) Massive 30% Price Jump

GenoFocus (KOSDAQ:187420) Is Carrying A Fair Bit Of Debt

Aug 05
GenoFocus (KOSDAQ:187420) Is Carrying A Fair Bit Of Debt

Is GenoFocus (KOSDAQ:187420) A Risky Investment?

Apr 13
Is GenoFocus (KOSDAQ:187420) A Risky Investment?

Can You Imagine How GenoFocus' (KOSDAQ:187420) Shareholders Feel About The 55% Share Price Increase?

Feb 16
Can You Imagine How GenoFocus' (KOSDAQ:187420) Shareholders Feel About The 55% Share Price Increase?

Is GenoFocus (KOSDAQ:187420) A Risky Investment?

Dec 22
Is GenoFocus (KOSDAQ:187420) A Risky Investment?

CEO

Eui-Joong Kim

no data

Tenure

Eui-Joong Kim serves as the Chief Executive Officer of Geno Focus, Inc. Eui-Joong Kim served as President of the Research Group at Korea Biotechnology Industry. Eui-Joong Kim is Adjunct Professor of System...